

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 6.50929384 |
| 2 | central nervous system myelination (GO:0022010) | 6.50929384 |
| 3 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.05964931 |
| 4 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.77538072 |
| 5 | ATP synthesis coupled proton transport (GO:0015986) | 5.77538072 |
| 6 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.67339082 |
| 7 | fatty acid elongation (GO:0030497) | 5.08627222 |
| 8 | respiratory electron transport chain (GO:0022904) | 4.76530301 |
| 9 | electron transport chain (GO:0022900) | 4.67150573 |
| 10 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.63976209 |
| 11 | protein neddylation (GO:0045116) | 4.54724350 |
| 12 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.49497342 |
| 13 | chaperone-mediated protein transport (GO:0072321) | 4.26083921 |
| 14 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.25698875 |
| 15 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.17477329 |
| 16 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.15271677 |
| 17 | negative regulation of ligase activity (GO:0051352) | 4.06545428 |
| 18 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.06545428 |
| 19 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.02577155 |
| 20 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.98453261 |
| 21 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.98453261 |
| 22 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.98234324 |
| 23 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.98234324 |
| 24 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.98234324 |
| 25 | platelet dense granule organization (GO:0060155) | 3.79941278 |
| 26 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.78662651 |
| 27 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.75526627 |
| 28 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.75526627 |
| 29 | cullin deneddylation (GO:0010388) | 3.75280078 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.71491684 |
| 31 | dopamine biosynthetic process (GO:0042416) | 3.70701234 |
| 32 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.69956558 |
| 33 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.67239242 |
| 34 | signal peptide processing (GO:0006465) | 3.61884410 |
| 35 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.61057704 |
| 36 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.60433974 |
| 37 | NADH dehydrogenase complex assembly (GO:0010257) | 3.60433974 |
| 38 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.60433974 |
| 39 | protein complex biogenesis (GO:0070271) | 3.57605325 |
| 40 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.57041160 |
| 41 | protein deneddylation (GO:0000338) | 3.56205861 |
| 42 | termination of RNA polymerase III transcription (GO:0006386) | 3.52467173 |
| 43 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.52467173 |
| 44 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.47308877 |
| 45 | dopamine transport (GO:0015872) | 3.44326870 |
| 46 | positive regulation of ligase activity (GO:0051351) | 3.42404959 |
| 47 | regulation of cellular amine metabolic process (GO:0033238) | 3.41038545 |
| 48 | hydrogen ion transmembrane transport (GO:1902600) | 3.37981259 |
| 49 | regulation of mitochondrial translation (GO:0070129) | 3.35095687 |
| 50 | regulation of hexokinase activity (GO:1903299) | 3.31493733 |
| 51 | regulation of glucokinase activity (GO:0033131) | 3.31493733 |
| 52 | sequestering of actin monomers (GO:0042989) | 3.30919738 |
| 53 | peptidyl-histidine modification (GO:0018202) | 3.30599060 |
| 54 | C-terminal protein lipidation (GO:0006501) | 3.29928146 |
| 55 | protein-cofactor linkage (GO:0018065) | 3.29796764 |
| 56 | neurotransmitter uptake (GO:0001504) | 3.29240900 |
| 57 | cholesterol biosynthetic process (GO:0006695) | 3.25626201 |
| 58 | protein maturation by protein folding (GO:0022417) | 3.23375937 |
| 59 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.23060067 |
| 60 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.23060067 |
| 61 | protein targeting to mitochondrion (GO:0006626) | 3.22083754 |
| 62 | amyloid precursor protein metabolic process (GO:0042982) | 3.20361330 |
| 63 | negative regulation of neurotransmitter transport (GO:0051589) | 3.17986735 |
| 64 | proton transport (GO:0015992) | 3.17159253 |
| 65 | myelination (GO:0042552) | 3.16426472 |
| 66 | rRNA modification (GO:0000154) | 3.16000081 |
| 67 | DNA deamination (GO:0045006) | 3.14500145 |
| 68 | GTP biosynthetic process (GO:0006183) | 3.14323815 |
| 69 | substantia nigra development (GO:0021762) | 3.14271427 |
| 70 | hydrogen transport (GO:0006818) | 3.12358913 |
| 71 | ensheathment of neurons (GO:0007272) | 3.11367732 |
| 72 | axon ensheathment (GO:0008366) | 3.11367732 |
| 73 | * mannosylation (GO:0097502) | 3.08234663 |
| 74 | protein localization to mitochondrion (GO:0070585) | 3.06051839 |
| 75 | establishment of protein localization to mitochondrion (GO:0072655) | 3.04995836 |
| 76 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.00954466 |
| 77 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.99854830 |
| 78 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.99150658 |
| 79 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.98632696 |
| 80 | respiratory chain complex IV assembly (GO:0008535) | 2.97654865 |
| 81 | negative regulation of protein ubiquitination (GO:0031397) | 2.97512635 |
| 82 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.97479266 |
| 83 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.96921714 |
| 84 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.96921714 |
| 85 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.96706032 |
| 86 | ATP biosynthetic process (GO:0006754) | 2.95720834 |
| 87 | positive regulation of cell cycle arrest (GO:0071158) | 2.93694346 |
| 88 | C-terminal protein amino acid modification (GO:0018410) | 2.93542352 |
| 89 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.92883658 |
| 90 | neuron cell-cell adhesion (GO:0007158) | 2.92815991 |
| 91 | nucleotide transmembrane transport (GO:1901679) | 2.91707659 |
| 92 | sterol biosynthetic process (GO:0016126) | 2.91485155 |
| 93 | regulation of ligase activity (GO:0051340) | 2.88914454 |
| 94 | inner mitochondrial membrane organization (GO:0007007) | 2.87931379 |
| 95 | cellular copper ion homeostasis (GO:0006878) | 2.87840487 |
| 96 | cellular response to zinc ion (GO:0071294) | 2.86954101 |
| 97 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.85983302 |
| 98 | GPI anchor biosynthetic process (GO:0006506) | 2.83205142 |
| 99 | glycerophospholipid catabolic process (GO:0046475) | 2.78201608 |
| 100 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.74985015 |
| 101 | mitochondrial transport (GO:0006839) | 2.74956004 |
| 102 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.74676029 |
| 103 | response to redox state (GO:0051775) | 2.74283085 |
| 104 | intracellular protein transmembrane import (GO:0044743) | 2.74074289 |
| 105 | regulation of dopamine metabolic process (GO:0042053) | 2.72015310 |
| 106 | regulation of catecholamine metabolic process (GO:0042069) | 2.72015310 |
| 107 | phagosome maturation (GO:0090382) | 2.70911448 |
| 108 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.70435732 |
| 109 | regulation of cilium movement (GO:0003352) | 2.70432775 |
| 110 | isoprenoid biosynthetic process (GO:0008299) | 2.70108696 |
| 111 | phenol-containing compound catabolic process (GO:0019336) | 2.68261547 |
| 112 | presynaptic membrane organization (GO:0097090) | 2.68094267 |
| 113 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.67152200 |
| 114 | pseudouridine synthesis (GO:0001522) | 2.66648092 |
| 115 | proteasome assembly (GO:0043248) | 2.65458486 |
| 116 | negative regulation of protein localization to cell surface (GO:2000009) | 2.64558094 |
| 117 | GPI anchor metabolic process (GO:0006505) | 2.62659437 |
| 118 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.61888991 |
| 119 | protein peptidyl-prolyl isomerization (GO:0000413) | 2.60867765 |
| 120 | presynaptic membrane assembly (GO:0097105) | 2.60862617 |
| 121 | purine-containing compound salvage (GO:0043101) | 2.59460336 |
| 122 | protein K11-linked ubiquitination (GO:0070979) | 2.59364015 |
| 123 | translation (GO:0006412) | 2.59053170 |
| 124 | glutathione derivative metabolic process (GO:1901685) | 2.58743559 |
| 125 | glutathione derivative biosynthetic process (GO:1901687) | 2.58743559 |
| 126 | adenosine metabolic process (GO:0046085) | 2.58732505 |
| 127 | neurotransmitter catabolic process (GO:0042135) | 2.58696680 |
| 128 | positive regulation of TOR signaling (GO:0032008) | 2.58680446 |
| 129 | amyloid precursor protein catabolic process (GO:0042987) | 2.58657357 |
| 130 | copper ion homeostasis (GO:0055070) | 2.57812176 |
| 131 | cytochrome complex assembly (GO:0017004) | 2.57636667 |
| 132 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.54191015 |
| 133 | oligodendrocyte differentiation (GO:0048709) | 2.51611179 |
| 134 | catechol-containing compound biosynthetic process (GO:0009713) | 2.50754776 |
| 135 | catecholamine biosynthetic process (GO:0042423) | 2.50754776 |
| 136 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.48725780 |
| 137 | transferrin transport (GO:0033572) | 2.48017203 |
| 138 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.45036830 |
| 139 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.44623322 |
| 140 | ribosomal small subunit biogenesis (GO:0042274) | 2.43902786 |
| 141 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.42876503 |
| 142 | ER overload response (GO:0006983) | 2.39228114 |
| 143 | positive regulation of mitochondrial fission (GO:0090141) | 2.38416242 |
| 144 | regulation of feeding behavior (GO:0060259) | 2.36762701 |
| 145 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.34815842 |
| 146 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.34094731 |
| 147 | regulation of axon regeneration (GO:0048679) | 2.33351903 |
| 148 | regulation of neuron projection regeneration (GO:0070570) | 2.33351903 |
| 149 | viral protein processing (GO:0019082) | 2.33226785 |
| 150 | cotranslational protein targeting to membrane (GO:0006613) | 2.32567008 |
| 151 | pH reduction (GO:0045851) | 2.30678726 |
| 152 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.30418443 |
| 153 | virion attachment to host cell (GO:0019062) | 2.30074281 |
| 154 | adhesion of symbiont to host cell (GO:0044650) | 2.30074281 |
| 155 | intracellular pH reduction (GO:0051452) | 2.29233228 |
| 156 | UTP biosynthetic process (GO:0006228) | 2.28980032 |
| 157 | trivalent inorganic cation transport (GO:0072512) | 2.27561352 |
| 158 | ferric iron transport (GO:0015682) | 2.27561352 |
| 159 | autophagic vacuole fusion (GO:0000046) | 2.24539524 |
| 160 | protein localization to endoplasmic reticulum (GO:0070972) | 2.24218412 |
| 161 | neuron remodeling (GO:0016322) | 2.24175636 |
| 162 | nucleoside diphosphate catabolic process (GO:0009134) | 2.23470588 |
| 163 | positive regulation of protein homodimerization activity (GO:0090073) | 2.21819470 |
| 164 | protein targeting to ER (GO:0045047) | 2.21603791 |
| 165 | aldehyde catabolic process (GO:0046185) | 2.21399369 |
| 166 | eye photoreceptor cell differentiation (GO:0001754) | 2.21018118 |
| 167 | photoreceptor cell differentiation (GO:0046530) | 2.21018118 |
| 168 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.20933931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.04308537 |
| 2 | ELK1_19687146_ChIP-ChIP_HELA_Human | 3.17405140 |
| 3 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.12022191 |
| 4 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.82726135 |
| 5 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.73094748 |
| 6 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.66431871 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.46536727 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.45596767 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.32239304 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.31730100 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.26444378 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.22552825 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.20737995 |
| 14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.20431466 |
| 15 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.18643509 |
| 16 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.11234983 |
| 17 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.10854150 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.08609250 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.08373783 |
| 20 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.07778999 |
| 21 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.05858937 |
| 22 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.98306533 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.96981081 |
| 24 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.94323921 |
| 25 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.94063308 |
| 26 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.93388931 |
| 27 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.89863939 |
| 28 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.89241964 |
| 29 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.87681228 |
| 30 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.83883859 |
| 31 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.82363628 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.81995749 |
| 33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.77508267 |
| 34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.73982789 |
| 35 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73842075 |
| 36 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.73063683 |
| 37 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.73002843 |
| 38 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.71970916 |
| 39 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.70919888 |
| 40 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.70245263 |
| 41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.68570493 |
| 42 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.67916986 |
| 43 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.65581740 |
| 44 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.64321230 |
| 45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.64170219 |
| 46 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.62421578 |
| 47 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.61621394 |
| 48 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.61510698 |
| 49 | FUS_26573619_Chip-Seq_HEK293_Human | 1.60599003 |
| 50 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.59543387 |
| 51 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.59395313 |
| 52 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.58275177 |
| 53 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.55360443 |
| 54 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.53513291 |
| 55 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.52623200 |
| 56 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.49734882 |
| 57 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.49389334 |
| 58 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.49305396 |
| 59 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.48734327 |
| 60 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.48711415 |
| 61 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.48711415 |
| 62 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.48402411 |
| 63 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.48402411 |
| 64 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.46918940 |
| 65 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.46219094 |
| 66 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.45145763 |
| 67 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.43799837 |
| 68 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.42048720 |
| 69 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.41818537 |
| 70 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.40428539 |
| 71 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.36015017 |
| 72 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.35323549 |
| 73 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.30871771 |
| 74 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.30390853 |
| 75 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29470517 |
| 76 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.29221849 |
| 77 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.28654885 |
| 78 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.28350150 |
| 79 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.27063015 |
| 80 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.24824453 |
| 81 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.24437067 |
| 82 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.24130277 |
| 83 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.24035269 |
| 84 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.23773896 |
| 85 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.22517545 |
| 86 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.22399027 |
| 87 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.21296511 |
| 88 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.20985826 |
| 89 | * AR_20517297_ChIP-Seq_VCAP_Human | 1.20107736 |
| 90 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.19793288 |
| 91 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.16938011 |
| 92 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.16071934 |
| 93 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.15456211 |
| 94 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.15380813 |
| 95 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.15256312 |
| 96 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.15208266 |
| 97 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.14322485 |
| 98 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13243018 |
| 99 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.13225724 |
| 100 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.13120865 |
| 101 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.12897142 |
| 102 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.10398541 |
| 103 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.10398541 |
| 104 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.09242623 |
| 105 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.08074438 |
| 106 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.07534286 |
| 107 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.05924707 |
| 108 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.04667400 |
| 109 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.04504770 |
| 110 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.03778962 |
| 111 | EWS_26573619_Chip-Seq_HEK293_Human | 1.03747398 |
| 112 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.02425817 |
| 113 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.02391324 |
| 114 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.02099078 |
| 115 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.00889825 |
| 116 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.00734964 |
| 117 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.00345175 |
| 118 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.99074850 |
| 119 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.97341900 |
| 120 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.97341900 |
| 121 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.96819725 |
| 122 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96704018 |
| 123 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.96647770 |
| 124 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.96052893 |
| 125 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.95603135 |
| 126 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.95198176 |
| 127 | JUN_21703547_ChIP-Seq_K562_Human | 0.95099001 |
| 128 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94932158 |
| 129 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.94908318 |
| 130 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.94272105 |
| 131 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94244174 |
| 132 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.94118702 |
| 133 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.93283734 |
| 134 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.93152838 |
| 135 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.92947740 |
| 136 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.92418750 |
| 137 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.92106598 |
| 138 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90879610 |
| 139 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.90719140 |
| 140 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.90659924 |
| 141 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.89094372 |
| 142 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.86801819 |
| 143 | AR_25329375_ChIP-Seq_VCAP_Human | 0.86544754 |
| 144 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.86361073 |
| 145 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.84416510 |
| 146 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.84162441 |
| 147 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.83971713 |
| 148 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.82706747 |
| 149 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.82355652 |
| 150 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.82350525 |
| 151 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.81463518 |
| 152 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.80628538 |
| 153 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.79555714 |
| 154 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.77798351 |
| 155 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77129149 |
| 156 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.76653748 |
| 157 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.76059525 |
| 158 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.75934936 |
| 159 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.75464582 |
| 160 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.75296920 |
| 161 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.74014594 |
| 162 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.73828747 |
| 163 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.73009174 |
| 164 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.72682899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 3.83593751 |
| 2 | MP0001905_abnormal_dopamine_level | 3.60262771 |
| 3 | MP0001529_abnormal_vocalization | 3.36401961 |
| 4 | MP0002102_abnormal_ear_morphology | 3.13592913 |
| 5 | MP0000920_abnormal_myelination | 2.66789182 |
| 6 | MP0004147_increased_porphyrin_level | 2.62884410 |
| 7 | MP0003136_yellow_coat_color | 2.58589331 |
| 8 | MP0006276_abnormal_autonomic_nervous | 2.57894812 |
| 9 | MP0002277_abnormal_respiratory_mucosa | 2.50138982 |
| 10 | MP0006054_spinal_hemorrhage | 2.38384633 |
| 11 | MP0009379_abnormal_foot_pigmentation | 2.30706949 |
| 12 | MP0002139_abnormal_hepatobiliary_system | 2.21201367 |
| 13 | MP0005379_endocrine/exocrine_gland_phen | 2.19201307 |
| 14 | MP0001764_abnormal_homeostasis | 2.16541757 |
| 15 | MP0003329_amyloid_beta_deposits | 2.11683375 |
| 16 | MP0001440_abnormal_grooming_behavior | 2.09516563 |
| 17 | MP0005360_urolithiasis | 2.06985573 |
| 18 | MP0008875_abnormal_xenobiotic_pharmacok | 2.05350594 |
| 19 | MP0003718_maternal_effect | 2.05060936 |
| 20 | MP0010386_abnormal_urinary_bladder | 2.04447381 |
| 21 | MP0002736_abnormal_nociception_after | 2.01731008 |
| 22 | MP0002064_seizures | 2.01290094 |
| 23 | MP0009046_muscle_twitch | 1.95674397 |
| 24 | MP0005084_abnormal_gallbladder_morpholo | 1.94515629 |
| 25 | MP0002272_abnormal_nervous_system | 1.91987511 |
| 26 | MP0003690_abnormal_glial_cell | 1.91080557 |
| 27 | MP0005171_absent_coat_pigmentation | 1.87002269 |
| 28 | MP0009840_abnormal_foam_cell | 1.86613418 |
| 29 | MP0004270_analgesia | 1.85277134 |
| 30 | MP0002938_white_spotting | 1.83912362 |
| 31 | MP0009745_abnormal_behavioral_response | 1.79952195 |
| 32 | MP0009697_abnormal_copulation | 1.79332744 |
| 33 | MP0006035_abnormal_mitochondrial_morpho | 1.76307672 |
| 34 | MP0004142_abnormal_muscle_tone | 1.75664102 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.75183350 |
| 36 | MP0000372_irregular_coat_pigmentation | 1.75004388 |
| 37 | MP0002734_abnormal_mechanical_nocicepti | 1.74480953 |
| 38 | MP0003950_abnormal_plasma_membrane | 1.73137986 |
| 39 | MP0001968_abnormal_touch/_nociception | 1.70219553 |
| 40 | MP0005423_abnormal_somatic_nervous | 1.66957686 |
| 41 | MP0005075_abnormal_melanosome_morpholog | 1.62498607 |
| 42 | MP0002163_abnormal_gland_morphology | 1.59714803 |
| 43 | MP0002733_abnormal_thermal_nociception | 1.59306747 |
| 44 | MP0002837_dystrophic_cardiac_calcinosis | 1.58751975 |
| 45 | MP0001970_abnormal_pain_threshold | 1.57315442 |
| 46 | MP0002572_abnormal_emotion/affect_behav | 1.56834382 |
| 47 | MP0001984_abnormal_olfaction | 1.55788703 |
| 48 | MP0003786_premature_aging | 1.53696408 |
| 49 | MP0005409_darkened_coat_color | 1.52370487 |
| 50 | MP0003634_abnormal_glial_cell | 1.52037655 |
| 51 | MP0008058_abnormal_DNA_repair | 1.51763954 |
| 52 | MP0005332_abnormal_amino_acid | 1.50882694 |
| 53 | MP0001542_abnormal_bone_strength | 1.49468968 |
| 54 | MP0004742_abnormal_vestibular_system | 1.44459039 |
| 55 | MP0002638_abnormal_pupillary_reflex | 1.44237984 |
| 56 | MP0002876_abnormal_thyroid_physiology | 1.43916344 |
| 57 | MP0001486_abnormal_startle_reflex | 1.43777045 |
| 58 | MP0008877_abnormal_DNA_methylation | 1.42534638 |
| 59 | MP0002295_abnormal_pulmonary_circulatio | 1.41320508 |
| 60 | MP0009384_cardiac_valve_regurgitation | 1.39410189 |
| 61 | MP0008789_abnormal_olfactory_epithelium | 1.37808291 |
| 62 | MP0003635_abnormal_synaptic_transmissio | 1.36950832 |
| 63 | MP0001501_abnormal_sleep_pattern | 1.36461939 |
| 64 | MP0005058_abnormal_lysosome_morphology | 1.34293850 |
| 65 | MP0001502_abnormal_circadian_rhythm | 1.33741257 |
| 66 | MP0005551_abnormal_eye_electrophysiolog | 1.32012691 |
| 67 | MP0005408_hypopigmentation | 1.31472101 |
| 68 | MP0001986_abnormal_taste_sensitivity | 1.31123784 |
| 69 | MP0000516_abnormal_urinary_system | 1.28553653 |
| 70 | MP0005367_renal/urinary_system_phenotyp | 1.28553653 |
| 71 | MP0006072_abnormal_retinal_apoptosis | 1.28046877 |
| 72 | MP0005645_abnormal_hypothalamus_physiol | 1.27815944 |
| 73 | MP0002735_abnormal_chemical_nociception | 1.27762488 |
| 74 | MP0002132_abnormal_respiratory_system | 1.25008391 |
| 75 | MP0002067_abnormal_sensory_capabilities | 1.18131860 |
| 76 | MP0003122_maternal_imprinting | 1.18079754 |
| 77 | MP0000604_amyloidosis | 1.17300081 |
| 78 | MP0004924_abnormal_behavior | 1.16007562 |
| 79 | MP0005386_behavior/neurological_phenoty | 1.16007562 |
| 80 | MP0002909_abnormal_adrenal_gland | 1.14759024 |
| 81 | MP0001756_abnormal_urination | 1.13695291 |
| 82 | MP0002063_abnormal_learning/memory/cond | 1.13335831 |
| 83 | MP0005164_abnormal_response_to | 1.12077256 |
| 84 | MP0009785_altered_susceptibility_to | 1.11769911 |
| 85 | MP0008260_abnormal_autophagy | 1.10534409 |
| 86 | MP0000343_altered_response_to | 1.09938540 |
| 87 | MP0004019_abnormal_vitamin_homeostasis | 1.08716288 |
| 88 | MP0001664_abnormal_digestion | 1.08700364 |
| 89 | MP0010329_abnormal_lipoprotein_level | 1.08551831 |
| 90 | MP0004043_abnormal_pH_regulation | 1.08207680 |
| 91 | MP0003632_abnormal_nervous_system | 1.06977800 |
| 92 | MP0001324_abnormal_eye_pigmentation | 1.06975085 |
| 93 | MP0000778_abnormal_nervous_system | 1.05561017 |
| 94 | MP0002229_neurodegeneration | 1.05446943 |
| 95 | MP0002090_abnormal_vision | 1.03223551 |
| 96 | MP0003724_increased_susceptibility_to | 1.03206642 |
| 97 | MP0004134_abnormal_chest_morphology | 1.02395791 |
| 98 | MP0004272_abnormal_basement_membrane | 0.99242554 |
| 99 | MP0000647_abnormal_sebaceous_gland | 0.99174561 |
| 100 | MP0005085_abnormal_gallbladder_physiolo | 0.98558835 |
| 101 | MP0001485_abnormal_pinna_reflex | 0.97823036 |
| 102 | MP0006082_CNS_inflammation | 0.96081736 |
| 103 | MP0001963_abnormal_hearing_physiology | 0.95765448 |
| 104 | MP0008872_abnormal_physiological_respon | 0.95374919 |
| 105 | MP0002282_abnormal_trachea_morphology | 0.94922762 |
| 106 | MP0002653_abnormal_ependyma_morphology | 0.94849171 |
| 107 | MP0004885_abnormal_endolymph | 0.93277097 |
| 108 | MP0003011_delayed_dark_adaptation | 0.92637413 |
| 109 | MP0003186_abnormal_redox_activity | 0.92546999 |
| 110 | MP0005253_abnormal_eye_physiology | 0.91370160 |
| 111 | MP0005451_abnormal_body_composition | 0.91331400 |
| 112 | MP0005410_abnormal_fertilization | 0.90879708 |
| 113 | MP0001919_abnormal_reproductive_system | 0.90387445 |
| 114 | MP0002148_abnormal_hypersensitivity_rea | 0.89926587 |
| 115 | MP0000639_abnormal_adrenal_gland | 0.89647659 |
| 116 | MP0000538_abnormal_urinary_bladder | 0.89449141 |
| 117 | MP0002822_catalepsy | 0.88932486 |
| 118 | MP0002557_abnormal_social/conspecific_i | 0.88919942 |
| 119 | MP0005319_abnormal_enzyme/_coenzyme | 0.88711791 |
| 120 | MP0003806_abnormal_nucleotide_metabolis | 0.87171739 |
| 121 | MP0003191_abnormal_cellular_cholesterol | 0.87119131 |
| 122 | MP0005365_abnormal_bile_salt | 0.86946615 |
| 123 | MP0001853_heart_inflammation | 0.84905032 |
| 124 | MP0008469_abnormal_protein_level | 0.84589145 |
| 125 | MP0005310_abnormal_salivary_gland | 0.84530554 |
| 126 | MP0003631_nervous_system_phenotype | 0.84259986 |
| 127 | MP0003252_abnormal_bile_duct | 0.83930107 |
| 128 | MP0002693_abnormal_pancreas_physiology | 0.83715476 |
| 129 | MP0004858_abnormal_nervous_system | 0.83363307 |
| 130 | MP0002095_abnormal_skin_pigmentation | 0.83306979 |
| 131 | MP0000462_abnormal_digestive_system | 0.82504355 |
| 132 | MP0001661_extended_life_span | 0.82453934 |
| 133 | MP0000026_abnormal_inner_ear | 0.82011814 |
| 134 | MP0001188_hyperpigmentation | 0.81835251 |
| 135 | MP0002066_abnormal_motor_capabilities/c | 0.81649285 |
| 136 | MP0002332_abnormal_exercise_endurance | 0.80982346 |
| 137 | MP0005376_homeostasis/metabolism_phenot | 0.80724017 |
| 138 | MP0005535_abnormal_body_temperature | 0.80082080 |
| 139 | MP0003195_calcinosis | 0.78943850 |
| 140 | MP0005394_taste/olfaction_phenotype | 0.78377022 |
| 141 | MP0005499_abnormal_olfactory_system | 0.78377022 |
| 142 | MP0002882_abnormal_neuron_morphology | 0.78335699 |
| 143 | MP0000358_abnormal_cell_content/ | 0.77215563 |
| 144 | MP0004883_abnormal_blood_vessel | 0.76946621 |
| 145 | MP0000013_abnormal_adipose_tissue | 0.76920450 |
| 146 | MP0003183_abnormal_peptide_metabolism | 0.76894017 |
| 147 | MP0010030_abnormal_orbit_morphology | 0.76888767 |
| 148 | MP0006036_abnormal_mitochondrial_physio | 0.76207112 |
| 149 | MP0004133_heterotaxia | 0.75539915 |
| 150 | MP0000230_abnormal_systemic_arterial | 0.73813336 |
| 151 | MP0001346_abnormal_lacrimal_gland | 0.73608598 |
| 152 | MP0002752_abnormal_somatic_nervous | 0.72139122 |
| 153 | MP0005636_abnormal_mineral_homeostasis | 0.72102990 |
| 154 | MP0005389_reproductive_system_phenotype | 0.70824470 |
| 155 | MP0009764_decreased_sensitivity_to | 0.70780941 |
| 156 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70520252 |
| 157 | MP0002928_abnormal_bile_duct | 0.69102705 |
| 158 | MP0000569_abnormal_digit_pigmentation | 0.69080404 |
| 159 | MP0005395_other_phenotype | 0.68462610 |
| 160 | MP0008873_increased_physiological_sensi | 0.68162525 |
| 161 | MP0003638_abnormal_response/metabolism_ | 0.67305182 |
| 162 | MP0009643_abnormal_urine_homeostasis | 0.67304609 |
| 163 | MP0002254_reproductive_system_inflammat | 0.65116952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.27078738 |
| 2 | Mitochondrial inheritance (HP:0001427) | 4.71171951 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.54855733 |
| 4 | Progressive macrocephaly (HP:0004481) | 4.40791763 |
| 5 | Acute encephalopathy (HP:0006846) | 4.31580991 |
| 6 | Neurofibrillary tangles (HP:0002185) | 4.26605335 |
| 7 | Parakeratosis (HP:0001036) | 4.17347550 |
| 8 | Renal Fanconi syndrome (HP:0001994) | 4.09211816 |
| 9 | Hepatocellular necrosis (HP:0001404) | 4.05784146 |
| 10 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.95940539 |
| 11 | Increased hepatocellular lipid droplets (HP:0006565) | 3.76128580 |
| 12 | Increased CSF lactate (HP:0002490) | 3.74480435 |
| 13 | Generalized aminoaciduria (HP:0002909) | 3.47470405 |
| 14 | Hepatic necrosis (HP:0002605) | 3.43510033 |
| 15 | Type I transferrin isoform profile (HP:0003642) | 3.37608548 |
| 16 | Lipid accumulation in hepatocytes (HP:0006561) | 3.36843710 |
| 17 | Leukodystrophy (HP:0002415) | 3.07514218 |
| 18 | Abnormality of glycolysis (HP:0004366) | 3.02806975 |
| 19 | Increased serum pyruvate (HP:0003542) | 3.02806975 |
| 20 | 3-Methylglutaconic aciduria (HP:0003535) | 3.00005438 |
| 21 | Hypothermia (HP:0002045) | 2.98945180 |
| 22 | Abnormal protein glycosylation (HP:0012346) | 2.98922779 |
| 23 | Abnormal glycosylation (HP:0012345) | 2.98922779 |
| 24 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.98922779 |
| 25 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.98922779 |
| 26 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.98787855 |
| 27 | Limb dystonia (HP:0002451) | 2.90397452 |
| 28 | Cerebral inclusion bodies (HP:0100314) | 2.88778707 |
| 29 | Abnormality of renal resorption (HP:0011038) | 2.86175988 |
| 30 | Optic disc pallor (HP:0000543) | 2.77187177 |
| 31 | Respiratory failure (HP:0002878) | 2.75865230 |
| 32 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.72502483 |
| 33 | Retinal dysplasia (HP:0007973) | 2.69038890 |
| 34 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.65488243 |
| 35 | Neuroendocrine neoplasm (HP:0100634) | 2.64844585 |
| 36 | Cerebral edema (HP:0002181) | 2.63698235 |
| 37 | Pancreatic cysts (HP:0001737) | 2.61001312 |
| 38 | Reduced antithrombin III activity (HP:0001976) | 2.57746160 |
| 39 | Pheochromocytoma (HP:0002666) | 2.56508546 |
| 40 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.54462157 |
| 41 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.54462157 |
| 42 | Lethargy (HP:0001254) | 2.54193030 |
| 43 | Pancreatic fibrosis (HP:0100732) | 2.51965615 |
| 44 | Congenital, generalized hypertrichosis (HP:0004540) | 2.51396136 |
| 45 | Medial flaring of the eyebrow (HP:0010747) | 2.50528505 |
| 46 | Cerebral hemorrhage (HP:0001342) | 2.49093305 |
| 47 | Renal cortical cysts (HP:0000803) | 2.43980302 |
| 48 | Gait imbalance (HP:0002141) | 2.42417568 |
| 49 | Increased intramyocellular lipid droplets (HP:0012240) | 2.42374737 |
| 50 | Exercise intolerance (HP:0003546) | 2.39671627 |
| 51 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.38116395 |
| 52 | Vaginal atresia (HP:0000148) | 2.37381530 |
| 53 | Exertional dyspnea (HP:0002875) | 2.36319950 |
| 54 | Congenital primary aphakia (HP:0007707) | 2.35805967 |
| 55 | Vacuolated lymphocytes (HP:0001922) | 2.35231531 |
| 56 | Genital tract atresia (HP:0001827) | 2.34890233 |
| 57 | Nausea (HP:0002018) | 2.30137533 |
| 58 | Lactic acidosis (HP:0003128) | 2.28805959 |
| 59 | Molar tooth sign on MRI (HP:0002419) | 2.27531079 |
| 60 | Abnormality of midbrain morphology (HP:0002418) | 2.27531079 |
| 61 | Supranuclear gaze palsy (HP:0000605) | 2.26351076 |
| 62 | Hypoplastic left heart (HP:0004383) | 2.25625880 |
| 63 | Hypoglycemic coma (HP:0001325) | 2.25162668 |
| 64 | Nephrogenic diabetes insipidus (HP:0009806) | 2.21809658 |
| 65 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.21254735 |
| 66 | Synostosis involving the elbow (HP:0003938) | 2.17309644 |
| 67 | Humeroradial synostosis (HP:0003041) | 2.17309644 |
| 68 | Spastic paraparesis (HP:0002313) | 2.17244158 |
| 69 | Abnormality of the axillary hair (HP:0100134) | 2.15380107 |
| 70 | Abnormality of secondary sexual hair (HP:0009888) | 2.15380107 |
| 71 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.14418720 |
| 72 | True hermaphroditism (HP:0010459) | 2.14156340 |
| 73 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.12482300 |
| 74 | Tongue fasciculations (HP:0001308) | 2.10483247 |
| 75 | Autoamputation (HP:0001218) | 2.09580065 |
| 76 | X-linked dominant inheritance (HP:0001423) | 2.08089437 |
| 77 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.06646620 |
| 78 | Dicarboxylic aciduria (HP:0003215) | 2.06646620 |
| 79 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.05409486 |
| 80 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.05409486 |
| 81 | Hyperglycinemia (HP:0002154) | 2.04015988 |
| 82 | Hyperalaninemia (HP:0003348) | 1.99982612 |
| 83 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.99982612 |
| 84 | Abnormality of alanine metabolism (HP:0010916) | 1.99982612 |
| 85 | Sensory axonal neuropathy (HP:0003390) | 1.99696757 |
| 86 | Aplastic anemia (HP:0001915) | 1.99618169 |
| 87 | Abnormality of vitamin B metabolism (HP:0004340) | 1.96774201 |
| 88 | Abnormality of the renal cortex (HP:0011035) | 1.96263969 |
| 89 | Degeneration of anterior horn cells (HP:0002398) | 1.96259141 |
| 90 | Abnormality of the anterior horn cell (HP:0006802) | 1.96259141 |
| 91 | Nephronophthisis (HP:0000090) | 1.95599978 |
| 92 | Increased muscle lipid content (HP:0009058) | 1.94345084 |
| 93 | Abnormality of methionine metabolism (HP:0010901) | 1.93731309 |
| 94 | Glycosuria (HP:0003076) | 1.92904208 |
| 95 | Abnormality of urine glucose concentration (HP:0011016) | 1.92904208 |
| 96 | Delayed gross motor development (HP:0002194) | 1.92614136 |
| 97 | Testicular atrophy (HP:0000029) | 1.92039187 |
| 98 | Hypoplastic pelvis (HP:0008839) | 1.91954071 |
| 99 | Abnormality of serum amino acid levels (HP:0003112) | 1.90929833 |
| 100 | Increased serum lactate (HP:0002151) | 1.89679052 |
| 101 | Sparse eyelashes (HP:0000653) | 1.89649164 |
| 102 | Hypoplastic heart (HP:0001961) | 1.89405565 |
| 103 | Split foot (HP:0001839) | 1.89243456 |
| 104 | Patchy hypopigmentation of hair (HP:0011365) | 1.87098590 |
| 105 | Abnormal pupillary function (HP:0007686) | 1.86545022 |
| 106 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.86452864 |
| 107 | Progressive neurologic deterioration (HP:0002344) | 1.85553452 |
| 108 | Abnormal ciliary motility (HP:0012262) | 1.83846029 |
| 109 | Respiratory difficulties (HP:0002880) | 1.83819441 |
| 110 | Palpitations (HP:0001962) | 1.82261291 |
| 111 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.81010116 |
| 112 | Delayed CNS myelination (HP:0002188) | 1.80689090 |
| 113 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.77752278 |
| 114 | Methylmalonic aciduria (HP:0012120) | 1.75738954 |
| 115 | CNS demyelination (HP:0007305) | 1.74939212 |
| 116 | Muscle fibrillation (HP:0010546) | 1.73986419 |
| 117 | Delusions (HP:0000746) | 1.73535196 |
| 118 | Emotional lability (HP:0000712) | 1.72971252 |
| 119 | Prolonged neonatal jaundice (HP:0006579) | 1.72412888 |
| 120 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.71377533 |
| 121 | Blindness (HP:0000618) | 1.71347797 |
| 122 | Methylmalonic acidemia (HP:0002912) | 1.70803689 |
| 123 | Paralysis (HP:0003470) | 1.69407686 |
| 124 | Short tibia (HP:0005736) | 1.69208428 |
| 125 | Hypokinesia (HP:0002375) | 1.68695667 |
| 126 | Abnormal number of erythroid precursors (HP:0012131) | 1.68038689 |
| 127 | Focal motor seizures (HP:0011153) | 1.67604428 |
| 128 | Hyperphosphaturia (HP:0003109) | 1.67045638 |
| 129 | Cerebral hypomyelination (HP:0006808) | 1.66269812 |
| 130 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.66148247 |
| 131 | Hypomagnesemia (HP:0002917) | 1.65982521 |
| 132 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.64883801 |
| 133 | Atonic seizures (HP:0010819) | 1.64032549 |
| 134 | Congenital stationary night blindness (HP:0007642) | 1.63722784 |
| 135 | Bile duct proliferation (HP:0001408) | 1.63179669 |
| 136 | Abnormal biliary tract physiology (HP:0012439) | 1.63179669 |
| 137 | Hypoplasia of the uterus (HP:0000013) | 1.62972965 |
| 138 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.62383584 |
| 139 | Peripheral hypomyelination (HP:0007182) | 1.62075497 |
| 140 | Metaphyseal dysplasia (HP:0100255) | 1.61611507 |
| 141 | Sensorimotor neuropathy (HP:0007141) | 1.61610603 |
| 142 | Abnormality of macrophages (HP:0004311) | 1.60105705 |
| 143 | Aplasia of the phalanges of the hand (HP:0009802) | 1.59791078 |
| 144 | Aplasia involving bones of the extremities (HP:0009825) | 1.59791078 |
| 145 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.59791078 |
| 146 | Brushfield spots (HP:0001088) | 1.59602256 |
| 147 | Abnormality of placental membranes (HP:0011409) | 1.59439595 |
| 148 | Amniotic constriction ring (HP:0009775) | 1.59439595 |
| 149 | Abnormality of dentin (HP:0010299) | 1.58854092 |
| 150 | White forelock (HP:0002211) | 1.58822265 |
| 151 | Irregular vertebral endplates (HP:0003301) | 1.58611918 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 3.62627027 |
| 2 | STK39 | 3.37326913 |
| 3 | ARAF | 3.06155432 |
| 4 | MAP3K12 | 2.91876371 |
| 5 | MST4 | 2.91812428 |
| 6 | PBK | 2.68824338 |
| 7 | MAPKAPK5 | 2.67978095 |
| 8 | OXSR1 | 2.56509287 |
| 9 | MAP4K2 | 2.39041140 |
| 10 | CASK | 2.20120788 |
| 11 | PDK2 | 2.18581228 |
| 12 | NUAK1 | 2.16656139 |
| 13 | TRIM28 | 2.02669438 |
| 14 | EIF2AK1 | 2.01495978 |
| 15 | ZAK | 1.97984609 |
| 16 | MYLK | 1.94710746 |
| 17 | BCR | 1.94468873 |
| 18 | FRK | 1.93603381 |
| 19 | STK16 | 1.92533086 |
| 20 | TNIK | 1.88847386 |
| 21 | ADRBK2 | 1.80282511 |
| 22 | WNK4 | 1.80238873 |
| 23 | MAPK15 | 1.75629513 |
| 24 | TESK1 | 1.68730121 |
| 25 | PNCK | 1.68599908 |
| 26 | GRK7 | 1.66693504 |
| 27 | BMPR1B | 1.65099372 |
| 28 | NME2 | 1.63307691 |
| 29 | NME1 | 1.61476199 |
| 30 | MUSK | 1.60647229 |
| 31 | EPHA4 | 1.59420593 |
| 32 | PIM2 | 1.49745844 |
| 33 | BMPR2 | 1.46782514 |
| 34 | CDK19 | 1.41176901 |
| 35 | CSNK1G3 | 1.40899009 |
| 36 | LIMK1 | 1.39411064 |
| 37 | MAP2K7 | 1.38772408 |
| 38 | PKN1 | 1.34245628 |
| 39 | EPHB1 | 1.31528286 |
| 40 | PINK1 | 1.29451188 |
| 41 | ERBB3 | 1.29357767 |
| 42 | PLK3 | 1.24243181 |
| 43 | MAP3K13 | 1.23476285 |
| 44 | NTRK1 | 1.22688407 |
| 45 | GRK5 | 1.22188942 |
| 46 | BRAF | 1.21316901 |
| 47 | CAMK2B | 1.21001838 |
| 48 | TESK2 | 1.19921533 |
| 49 | TLK1 | 1.13622601 |
| 50 | PRKCE | 1.12411239 |
| 51 | MET | 1.11864303 |
| 52 | NEK6 | 1.10620260 |
| 53 | MAPK13 | 1.09889098 |
| 54 | CAMK2D | 1.08464378 |
| 55 | MOS | 1.07746300 |
| 56 | CAMK2A | 1.07081513 |
| 57 | MAP3K3 | 1.06600367 |
| 58 | ACVR1B | 1.04672401 |
| 59 | CAMK2G | 0.99198633 |
| 60 | ADRBK1 | 0.97632058 |
| 61 | DYRK2 | 0.95657720 |
| 62 | ROCK2 | 0.94716846 |
| 63 | CSNK1G2 | 0.93915351 |
| 64 | RIPK4 | 0.89975124 |
| 65 | FGR | 0.89851912 |
| 66 | WEE1 | 0.89042648 |
| 67 | PLK2 | 0.88123491 |
| 68 | WNK3 | 0.87270121 |
| 69 | CSNK1G1 | 0.87014832 |
| 70 | PAK4 | 0.86251633 |
| 71 | TAOK3 | 0.82562228 |
| 72 | MAPKAPK3 | 0.81544792 |
| 73 | MAP3K14 | 0.75920901 |
| 74 | TAF1 | 0.75289107 |
| 75 | FLT3 | 0.72404750 |
| 76 | VRK1 | 0.72080970 |
| 77 | SIK3 | 0.71920651 |
| 78 | CAMKK2 | 0.71159802 |
| 79 | UHMK1 | 0.69930762 |
| 80 | PIK3CG | 0.69584943 |
| 81 | CDK8 | 0.68986397 |
| 82 | BCKDK | 0.66925379 |
| 83 | BRSK2 | 0.66550421 |
| 84 | ABL2 | 0.66147237 |
| 85 | BUB1 | 0.66066531 |
| 86 | TIE1 | 0.65681378 |
| 87 | INSRR | 0.65621446 |
| 88 | DAPK1 | 0.64553466 |
| 89 | MAP2K6 | 0.64407793 |
| 90 | SGK494 | 0.64363092 |
| 91 | SGK223 | 0.64363092 |
| 92 | MST1R | 0.63882328 |
| 93 | TGFBR1 | 0.61522139 |
| 94 | PRKCG | 0.60249269 |
| 95 | MAP3K2 | 0.59705856 |
| 96 | KDR | 0.59323227 |
| 97 | FES | 0.58545481 |
| 98 | PAK3 | 0.58403881 |
| 99 | MAP2K2 | 0.57023773 |
| 100 | EIF2AK3 | 0.56785815 |
| 101 | TSSK6 | 0.56141358 |
| 102 | PRKCQ | 0.55902825 |
| 103 | TXK | 0.55669771 |
| 104 | MAP3K4 | 0.55393995 |
| 105 | CDK3 | 0.54215401 |
| 106 | CDK14 | 0.53812292 |
| 107 | GRK1 | 0.53792858 |
| 108 | NTRK3 | 0.53413398 |
| 109 | TNK2 | 0.52865105 |
| 110 | PASK | 0.52143483 |
| 111 | EPHA3 | 0.51823191 |
| 112 | IKBKB | 0.51730902 |
| 113 | CDK5 | 0.51253719 |
| 114 | DAPK3 | 0.51159913 |
| 115 | PRKACA | 0.51054540 |
| 116 | MAPK12 | 0.49996027 |
| 117 | FER | 0.49402042 |
| 118 | CSNK1A1L | 0.49243284 |
| 119 | PIK3CA | 0.49205570 |
| 120 | OBSCN | 0.49150799 |
| 121 | NTRK2 | 0.49063236 |
| 122 | ERBB4 | 0.47863193 |
| 123 | CDK18 | 0.45632111 |
| 124 | CDK15 | 0.45426466 |
| 125 | CSNK2A1 | 0.44670718 |
| 126 | ILK | 0.44492844 |
| 127 | EPHB2 | 0.43933859 |
| 128 | SRPK1 | 0.43557016 |
| 129 | CSNK2A2 | 0.42117243 |
| 130 | NEK1 | 0.42102683 |
| 131 | PRKCI | 0.41784970 |
| 132 | CDK11A | 0.41770011 |
| 133 | PTK2B | 0.41536786 |
| 134 | YES1 | 0.40979049 |
| 135 | TGFBR2 | 0.40784436 |
| 136 | PHKG2 | 0.39836699 |
| 137 | PHKG1 | 0.39836699 |
| 138 | PRKCD | 0.37120389 |
| 139 | PRKCA | 0.36957182 |
| 140 | PLK1 | 0.36846525 |
| 141 | PRKG1 | 0.36630733 |
| 142 | RPS6KA5 | 0.36175932 |
| 143 | EIF2AK2 | 0.33037588 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 5.21506361 |
| 2 | Protein export_Homo sapiens_hsa03060 | 4.10473512 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 4.06039946 |
| 4 | Alzheimers disease_Homo sapiens_hsa05010 | 3.21144435 |
| 5 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.14006277 |
| 6 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.92676921 |
| 7 | Huntingtons disease_Homo sapiens_hsa05016 | 2.66163214 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.64804338 |
| 9 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.55966321 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.55521946 |
| 11 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.48453355 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 2.27078060 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.24064428 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.08406447 |
| 15 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.07445881 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.89739762 |
| 17 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.78883713 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.69242844 |
| 19 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.64901053 |
| 20 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.62671124 |
| 21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.49810670 |
| 22 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.48945882 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.48005886 |
| 24 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.44656203 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.40958035 |
| 26 | RNA polymerase_Homo sapiens_hsa03020 | 1.40666622 |
| 27 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.40390266 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.33862591 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.31656297 |
| 30 | Basal transcription factors_Homo sapiens_hsa03022 | 1.29557426 |
| 31 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.24564934 |
| 32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.24168814 |
| 33 | Mismatch repair_Homo sapiens_hsa03430 | 1.21076388 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.19228667 |
| 35 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.18604881 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.17362503 |
| 37 | Nicotine addiction_Homo sapiens_hsa05033 | 1.13950073 |
| 38 | Phagosome_Homo sapiens_hsa04145 | 1.10305265 |
| 39 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.09536341 |
| 40 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.04519934 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01257597 |
| 42 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.99428366 |
| 43 | GABAergic synapse_Homo sapiens_hsa04727 | 0.98993130 |
| 44 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.97525450 |
| 45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.95452162 |
| 46 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.95216935 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 0.94021099 |
| 48 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.93274897 |
| 49 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.93121985 |
| 50 | Cocaine addiction_Homo sapiens_hsa05030 | 0.88695551 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88139088 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87160722 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.86533757 |
| 54 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.85435078 |
| 55 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.84905265 |
| 56 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.83184262 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 0.81645669 |
| 58 | Metabolic pathways_Homo sapiens_hsa01100 | 0.79901370 |
| 59 | RNA degradation_Homo sapiens_hsa03018 | 0.79553106 |
| 60 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.78723293 |
| 61 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.77953609 |
| 62 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.77906668 |
| 63 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77641148 |
| 64 | Retinol metabolism_Homo sapiens_hsa00830 | 0.76154995 |
| 65 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75780211 |
| 66 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.74128323 |
| 67 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.73276843 |
| 68 | Peroxisome_Homo sapiens_hsa04146 | 0.72990667 |
| 69 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.72969849 |
| 70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72828453 |
| 71 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.70375481 |
| 72 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.68893245 |
| 73 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.68277199 |
| 74 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.68204529 |
| 75 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.67668101 |
| 76 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67609730 |
| 77 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.65058584 |
| 78 | Malaria_Homo sapiens_hsa05144 | 0.63352858 |
| 79 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.62906567 |
| 80 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62732199 |
| 81 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.60951508 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.60601389 |
| 83 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.59440584 |
| 84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59273331 |
| 85 | Base excision repair_Homo sapiens_hsa03410 | 0.59105624 |
| 86 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.57402957 |
| 87 | Morphine addiction_Homo sapiens_hsa05032 | 0.57289287 |
| 88 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.55943672 |
| 89 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.55531644 |
| 90 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.55263691 |
| 91 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.55162350 |
| 92 | Phototransduction_Homo sapiens_hsa04744 | 0.53449286 |
| 93 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.52959285 |
| 94 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.51013767 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.50943770 |
| 96 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50812103 |
| 97 | Long-term depression_Homo sapiens_hsa04730 | 0.48566159 |
| 98 | Taste transduction_Homo sapiens_hsa04742 | 0.47999500 |
| 99 | RNA transport_Homo sapiens_hsa03013 | 0.47621723 |
| 100 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.47497316 |
| 101 | Allograft rejection_Homo sapiens_hsa05330 | 0.47106681 |
| 102 | Spliceosome_Homo sapiens_hsa03040 | 0.46429303 |
| 103 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44806280 |
| 104 | Carbon metabolism_Homo sapiens_hsa01200 | 0.42604015 |
| 105 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.41761583 |
| 106 | DNA replication_Homo sapiens_hsa03030 | 0.41438988 |
| 107 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.41015938 |
| 108 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.39392465 |
| 109 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38821088 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | 0.37954735 |
| 111 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.36447004 |
| 112 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.36196312 |
| 113 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.35685583 |
| 114 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.35510465 |
| 115 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.35188381 |
| 116 | Axon guidance_Homo sapiens_hsa04360 | 0.35056485 |
| 117 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.35042298 |
| 118 | Legionellosis_Homo sapiens_hsa05134 | 0.34871166 |
| 119 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.34599712 |
| 120 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34158451 |
| 121 | Insulin secretion_Homo sapiens_hsa04911 | 0.33848905 |
| 122 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.33484920 |
| 123 | Salivary secretion_Homo sapiens_hsa04970 | 0.32642896 |
| 124 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.32578730 |
| 125 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.32408237 |
| 126 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31766074 |
| 127 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.29997534 |
| 128 | Asthma_Homo sapiens_hsa05310 | 0.29436085 |
| 129 | Circadian entrainment_Homo sapiens_hsa04713 | 0.28732926 |
| 130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28407923 |
| 131 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.28340282 |
| 132 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28115549 |
| 133 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.26003469 |
| 134 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.25993466 |
| 135 | Purine metabolism_Homo sapiens_hsa00230 | 0.25041193 |
| 136 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.23790212 |
| 137 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.23402697 |
| 138 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.23203690 |
| 139 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.22935673 |
| 140 | Prion diseases_Homo sapiens_hsa05020 | 0.21969798 |
| 141 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.20238943 |
| 142 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.19974065 |
| 143 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.19044300 |

